NCT05060354View on ClinicalTrials.gov

COVID-19 Vaccine Response in Treated MS Patients

CompletedOBSERVATIONAL
Enrollment

159

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

September 15, 2023

Study Completion Date

September 28, 2023

Conditions
Multiple SclerosisHealthy
Interventions
OTHER

Blood draw

Approximately 120 mL whole blood will be collected from each subject at each timepoint

Trial Locations (1)

02115

Brigham MS Center, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER